XRF SCIENTIFIC LIMITED (XRF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

XRF - XRF SCIENTIFIC LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: 0.31
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.535

22 Jul
2024

0.015

OPEN

$1.53

0.99%

HIGH

$1.54

238,560

LOW

$1.50

OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . C79 . CDA . CDD . DCG . DOW . EHL . GNG . IMD . IPG . IPL . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . RDG . RUL . SRG . SVW . SXE .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 01/10 - ex-div 1.4c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx5.6
DPS All xxxxxxxxxxxxxxx3.3
Sales/Revenue xxxxxxxxxxxxxxx55.2 M
Book Value Per Share xxxxxxxxxxxxxxx35.9
Net Operating Cash Flow xxxxxxxxxxxxxxx8.4 M
Net Profit Margin xxxxxxxxxxxxxxx13.93 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx16.58 %
Return on Invested Capital xxxxxxxxxxxxxxx15.77 %
Return on Assets xxxxxxxxxxxxxxx12.69 %
Return on Equity xxxxxxxxxxxxxxx16.58 %
Return on Total Capital xxxxxxxxxxxxxxx25.33 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx5.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx16 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx10 M
Price To Book Value xxxxxxxxxxxxxxx3.26

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.8 M
Capex % of Sales xxxxxxxxxxxxxxx1.42 %
Cost of Goods Sold xxxxxxxxxxxxxxx33 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx9 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Canaccord Genuity

23/02/2024

1

Upgrade to Speculative Buy from Hold

$1.30

-15.31%

XRF Scientific impressed Canaccord Genuity with its first half results, considering the market had slowed throughout 2023. Revenue and EBITDA were slightly ahead of expectations.

On a FY25 PE of 15.9x, the broker believes the company has started the second half on a strong run rate with the potential for upside.

Rating is upgraded to Speculative Buy from Hold and the target lifted to $1.30 from $1.22. The broker envisages valuation upside although the lumpy revenue and earnings means a heightened level of risk.

FORECAST
Canaccord Genuity forecasts a full year FY24 dividend of 3.10 cents and EPS of 6.50 cents.
Canaccord Genuity forecasts a full year FY25 dividend of 3.50 cents and EPS of 7.30 cents.

XRF STOCK CHART